Every 8-K that Ares Capital Corporation (ARCC) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 8-K covers material events a company has to report between its quarterly reports, so if you follow ARCC and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full ARCC filings page.
ARES CAPITAL CORP (ARCC) entered into a Seventh Supplemental Indenture with U.S. Bank Trust Company to issue, offer and sell $750,000,000 aggregate principal amount of 6.250% notes due 2033. The notes are direct unsecured obligations, mature on September 15, 2033, and pay interest at 6.250% per year, semiannually on March 15 and September 15, starting March 15, 2027.
The company expects to use the net proceeds to repay outstanding indebtedness under its credit facilities and may subsequently reborrow for general corporate purposes, including investing in portfolio companies. The Indenture includes covenants tied to Investment Company Act leverage limits and ongoing financial information delivery if Exchange Act reporting ceases, subject to stated limitations and exceptions.
Upon a change of control repurchase event, Ares Capital must offer to repurchase the notes at 100% of principal plus accrued and unpaid interest. In connection with the issuance, the company entered into a $750,000,000 interest rate swap with JPMorgan Chase Bank to receive 6.250% fixed and pay a floating rate based on three-month SOFR + 1.85250%, with the swap maturing on September 15, 2033.
Ares Capital Corporation reported the results of a special meeting of stockholders held on August 13, 2026. Stockholders were asked to authorize the company, with board approval, to sell or issue common stock at a price below its then current net asset value per share, subject to limits.
The company stated that 718,022,845 shares of common stock were entitled to vote as of May 15, 2026. The proposal was approved, with all stockholders casting 287,240,274 votes for, 70,093,164 against, and 14,771,898 abstentions. Excluding shares held by affiliated persons, votes for totaled 279,480,234, with the same against and abstain counts.
The authorization is limited so that the number of shares issued does not exceed 25% of the then outstanding common stock and will be effective for any such issuances during a twelve-month period expiring on August 13, 2027.
Ares Capital Corporation reported second quarter 2026 results with net investment income of $359 million ($0.50 per share), up from $342 million ($0.49) a year earlier. GAAP net income was $171 million ($0.24 per share), down from $361 million ($0.52), as net realized and unrealized results weakened.
Core EPS was $0.47 versus $0.50 in the prior-year quarter, against a regular quarterly dividend of $0.48 per share. At June 30, 2026, total investments at fair value were $29,349 million, net asset value per share was $19.35, and the debt-to-equity ratio was 1.15x.
Liquidity remained substantial, with $383 million in cash, approximately $15.9 billion of debt outstanding and approximately $6.7 billion available under credit facilities. The Board declared a third quarter 2026 dividend of $0.48 per share, payable September 30, 2026 to stockholders of record on September 15, 2026.
Ares Capital Corporation, through wholly owned subsidiary Ares Direct Lending CLO 1 LLC, completed a refinancing of its approximately $708.7 million term debt securitization on July 17, 2026. The reset establishes a new on-balance-sheet collateralized loan obligation structure maturing on July 25, 2038.
The transaction includes issuance of $267.0 million of Class A-1-R notes at Term SOFR plus 1.46%, $24.5 million of Class A-2-R notes at Term SOFR plus 1.70%, $45.5 million of Class B-R notes at Term SOFR plus 1.90%, and $7.1 million of additional Subordinated Notes, alongside $139.0 million of Class A-1-LR term loans at Term SOFR plus 1.46%, all due July 25, 2038.
The secured notes and loans are backed by a diversified portfolio of first lien senior secured loans contributed on May 24, 2024, with principal collections available through July 25, 2031 to purchase new collateral under Ares Capital Management LLC’s asset management mandate. Net proceeds were used to redeem in full $406.0 million of Class A and $70.0 million of Class B 2036 notes, fund ADL CLO 1 accounts, and pay related fees and expenses. Ares Capital retained all subordinated CLO notes, and the asset manager has agreed to waive management fees from ADL CLO 1.
Ares Capital Corporation entered into a Tenth Amendment to its BNP Paribas revolving credit and security agreement through its subsidiary ARCC FB Funding LLC. The amendment increased total lender commitments by $200 million, raising the facility size from $1.265 billion to $1.465 billion. The amendment also adjusted certain concentration limits and the advance rate on specific collateral loans, while leaving other key terms of the facility materially unchanged.
Ares Capital Corporation has established an inaugural commercial paper program that permits issuance of up to $1 billion in short-term, unsecured commercial paper notes. The notes may be issued at par or a discount, will have maturities of up to 397 days, and will rely on private placement exemptions from registration.
Net proceeds from any notes are expected to be used for general corporate purposes. The notes will rank pari passu with Ares Capital’s other senior unsecured indebtedness, and the company expects to use borrowing capacity from its $5.5 billion Revolving Credit Facility as a liquidity backstop for repayment of notes issued under the program.
Ares Capital Corporation amended and restated its senior secured credit facility, slightly increasing total commitments and loans from approximately $5.312 billion to approximately $5.481 billion. The facility now consists of a revolving loan tranche of about $4.3 billion and a term loan tranche of about $1.2 billion.
The company extended the revolving period and stated maturity for lenders that agreed to longer terms, with most extended maturities now running to May 21, 2031. An accordion feature permits potential expansion of the facility by up to approximately $2.7 billion, and the credit agreement includes detailed interest rate spreads over Term SOFR or an alternate base rate, plus commitment and letter of credit fees.
The facility remains secured by a material portion of Ares Capital’s assets and is subject to covenants such as maintaining minimum stockholders’ equity and a minimum 1.5:1.0 asset coverage ratio relative to total indebtedness, along with customary limitations on additional debt, liens, investments, asset transfers, and restricted payments.
Ares Capital Corporation entered into a Sixth Supplemental Indenture to issue $800,000,000 aggregate principal amount of its 5.550% notes due 2030. The notes are direct unsecured obligations, pay 5.550% interest semiannually starting on January 15, 2027, and mature on January 15, 2030. They may be redeemed at the company’s option at prices set in the indenture.
Ares Capital expects to use the net proceeds to repay outstanding borrowings under its credit facilities, with the ability to reborrow for general corporate purposes, including portfolio investments. The indenture includes covenants tied to Investment Company Act leverage limits and financial reporting if the company ceases to be an Exchange Act reporting company, plus a change of control repurchase feature at 100% of principal plus accrued interest.
In connection with the issuance, Ares Capital entered into an interest rate swap with a notional amount of $800,000,000, under which it receives fixed 5.550% and pays a floating rate based on one-month SOFR plus 1.69950% through January 15, 2030.
Ares Capital Corporation reported the results of its annual stockholder meeting held on May 7, 2026. Stockholders entitled to vote included 718,022,845 shares of common stock as of the record date of March 2, 2026.
Stockholders elected three Class I directors to serve until the 2029 annual meeting. Ann Torre Bates received 227,599,186 votes for, 22,887,186 against and 5,483,619 abstentions, with 256,591,998 broker non-votes. Steven B. McKeever received 193,224,033 votes for, 58,930,014 against and 3,815,944 abstentions, with 256,591,998 broker non-votes. Michael J. Arougheti received 234,472,961 votes for, 18,006,707 against and 3,490,323 abstentions, with 256,591,998 broker non-votes.
Stockholders also approved the ratification of KPMG LLP as the independent registered public accounting firm for the year ending December 31, 2026, with 490,881,757 votes for, 16,126,434 against and 5,553,798 abstentions.
Ares Capital Corporation entered new equity distribution agreements that allow it to issue and sell shares of its common stock with an aggregate offering price of up to $1,500,000,000 through multiple sales agents. These shares may be sold in negotiated deals or “at the market” transactions on the NASDAQ Global Select Market or through market makers at prices tied to prevailing or negotiated levels.
The sales agents, including Truist, Mizuho, RBC, Regions and SMBC, may earn commissions of up to 1.5% of the gross sales price of any shares sold. The company is not obligated to sell any shares and can suspend offerings at any time. On the same date, Ares Capital terminated prior equity distribution agreements from February 5, 2025 that have been superseded by these new arrangements.
Ares Capital Corporation reported first quarter 2026 results and declared a second quarter 2026 dividend of $0.48 per share, payable June 30, 2026 to stockholders of record on June 15, 2026.
For the quarter ended March 31, 2026, GAAP net income was $92 million, or $0.13 per share, compared with $241 million, or $0.36 per share, a year earlier, mainly reflecting higher net unrealized losses of $412 million. Net investment income increased to $398 million, or $0.55 per share, from $365 million, or $0.54 per share, while Core EPS was $0.47 versus $0.50.
Portfolio investments at fair value were $29.5 billion as of March 31, 2026, and net asset value per share was $19.59, slightly below $19.94 as of December 31, 2025. The debt/equity ratio was 1.13x, and loans on non-accrual status remained low at 2.1% of total investments at amortized cost and 1.2% at fair value.
Ares Capital highlighted approximately $6.0 billion of available liquidity, including $505 million of cash and $5.5 billion of capacity under credit facilities. During the quarter it issued $750 million of unsecured notes due 2031 at 5.250%, repaid $1,150 million of maturing 3.875% notes, and expanded its SMBC revolving funding facility from $1.1 billion to $1.6 billion while modestly reducing spreads.
Ares Capital Corporation updated a key borrowing facility with Sumitomo Mitsui Banking Corporation and other lenders. The amendment increases total commitments under the SMBC Funding Facility from $1.1 billion to $1.6 billion, giving the company more committed debt capacity for its lending activities.
The pricing on the facility improves slightly, with the applicable spread reduced from 1.80% to 1.75% over SOFR, or from 0.80% to 0.75% over a defined base rate. The amendment also expands the accordion feature, allowing potential upsizing of the facility’s maximum size from $1.3 billion to $2.5 billion under certain conditions, while other terms remain materially unchanged.
Ares Capital Corporation reported that it has issued a press release announcing its financial results for the quarter and year ended December 31, 2025. The detailed numbers are contained in the accompanying press release referenced as an exhibit.
The company also declared a first quarter 2026 dividend of $0.48 per share, payable on March 31, 2026 to stockholders of record as of March 13, 2026. These updates were disclosed in a current report on Form 8-K.
Ares Capital Corporation entered into a Fifth Supplemental Indenture and completed the issuance, offer and sale of $750,000,000 aggregate principal amount of its 5.250% notes due 2031. The notes mature on April 12, 2031, bear interest at 5.250% per year, and pay interest semiannually on April 12 and October 12, starting April 12, 2026. They are direct unsecured obligations of the company and may be redeemed at the company’s option at the redemption prices set forth in the supplemental indenture.
The company expects to use the net proceeds to repay outstanding indebtedness under its credit facilities, with the ability to reborrow for general corporate purposes, including investments in portfolio companies. The indenture includes leverage-related covenants tied to Investment Company Act requirements and a change of control repurchase feature at 100% of principal plus accrued interest. In connection with the notes, Ares Capital also entered into an interest rate swap with a notional amount of $750,000,000, receiving fixed 5.250% and paying a floating rate based on one-month SOFR plus 1.7217% through April 12, 2031.
Ares Capital Corporation (ARCC) announced its financial results for the quarter ended September 30, 2025 via a press release furnished as Exhibit 99.1. The company also declared a fourth quarter 2025 dividend of $0.48 per share.
The dividend is payable on December 30, 2025 to stockholders of record as of December 15, 2025. The results press release was furnished under Item 2.02 and is not deemed filed under Section 18 of the Exchange Act.
Ares Capital Corporation filed an 8-K dated September 9, 2025 that attaches the form of 5.100% Notes due 2031 via a Fourth Supplemental Indenture and includes legal opinions and consents. The filing lists opinions from Venable LLP and Kirkland & Ellis LLP, with corresponding consents included in those opinions, and an Interactive Data File cover page. The document is signed by Scott C. Lem, Chief Financial Officer and Treasurer.
Ares Capital Corporation held a special meeting where shareholders authorized the board to sell or issue common stock at a price below the company's then-current net asset value per share, subject to limits. The authorization limits any such issuance to no more than 25% of outstanding common shares and is effective for a 12-month period expiring on August 8, 2026. The record date for voting showed 694,181,754 shares outstanding.
The inspector certified the vote: among all holders, 286,084,869 voted for, 63,903,043 against and 11,635,163 abstained. Excluding affiliated persons, the for vote was 279,483,225. The approval gives the board short-term flexibility to issue up to a capped amount of shares below NAV; it was adopted with clear but not unanimous support.